Viewing Study NCT03680560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-03-02 @ 3:43 PM
Study NCT ID: NCT03680560
Status: TERMINATED
Last Update Posted: 2020-03-31
First Post: 2018-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Sponsor: Cogent Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None HER-2 Protein Overexpression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None ACTR View
None ACTR087 View
None ACTR707 View
None T cell View
None T cell product View
None adoptive T cells View
None gene therapy View
None breast cancer View
None gastric cancer View
None gastro esophageal cancer View
None immunotherapy View
None solid tumor View
None adenoid cystic carcinoma View